QUOTE AND NEWS
Stock Blog Hub  Jan 23  Comment 
Recently, Meridian Bioscience Inc. (VIVO) reported results for the first quarter of fiscal 2010. The company earned 22 cents per share in the quarter which fell short of the Zacks Consensus Estimate by a penny. Meridian Bioscience earned 20 cents...
StreetInsider.com  Jan 21  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Meridian+Bioscience+%28VIVO%29+Posts+Q1+EPS+of+%240.22%2C+In-Line+with+Street%3B+Reaffirms+FY10+Guidance/5263339.html for the full story.
Business Wire  Jan 21  Comment 
Meridian Bioscience, Inc. (NASDAQ: VIVO): GENERAL HIGHLIGHTS Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today: reported record first quarter net sales of $42.5 million, an increase of 24%, over the same period of the prior fiscal
StreetInsider.com  Nov 12  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Meridian+Biosci.+%28VIVO%29+Posts+Q4+EPS+of+%240.22%2C+Tops+by+1c/5099441.html for the full story.
Business Wire  Nov 12  Comment 
Meridian Bioscience, Inc. (NASDAQ: VIVO): GENERAL HIGHLIGHTS Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today: reported record fourth quarter and full-year fiscal 2009 net sales of $42.5 million and $148.3 million, respectively,
StreetInsider.com  Oct 29  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/Sidoti+%26+Co+Upgrades+Meridien+Bioscience+%28VIVO%29+to+Buy+/5055440.html for the full story.
StreetInsider.com  Sep 15  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/Meridian+Bioscience+%28VIVO%29+Guides+FY10+EPS+Inline%2C+Sales+Above+the+Street/4946568.html for the full story.



Thank you for your suggestion


 
TOP CONTRIBUTORS


Meridian Bioscience is a life science company, engages in the development, manufacture, sale, and distribution of diagnostic test kits primarily for respiratory, gastrointestinal, viral, and parasitic infectious diseases. The immunodiagnostic technologies used in its diagnostic test kits include evarious popular methods used by reference laboratories, hospitals, and physicians' offices. The company also manufactures and distributes bulk antigens, antibodies, and reagents used by researchers and other diagnostic manufacturers.

Business Financials

On January 22, 2008, Meridian (VIVO) reported 1st quarter 2008 results. For the quarter ended December 31, 2007, sales increased 18% to $33.8 million from $28.7 million the prior year. Net earnings increased 34% to $7.5 million from $5.6 million the prior year, representing a 29% increase on a per share basis of $.18/share in 2008 vs. $.14/share in the prior year same period.





References

Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki